UB
BEAM icon

UMB Bank’s Beam Therapeutics BEAM Stock Holding History

UMB Bank’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-50
Closed -$1.19K – 2309
2026
Q1 		$1.19K Sell
50
-50
-50% -$1.39K ﹤0.01% 2204
2025
Q4 		$2.77K Hold
100
– – ﹤0.01% 2134
2025
Q3 		$2.43K Buy
+100
New +$1.99K ﹤0.01% 2022
2022
Q3 		– Sell
-52
Closed -$2K – 1758
2022
Q2 		$2K Hold
52
– – ﹤0.01% 1716
2022
Q1 		$3K Hold
52
– – ﹤0.01% 1740
2021
Q4 		$4K Buy
+52
New +$4.45K ﹤0.01% 1669

Other funds holding BEAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

UMB Bank's BEAM Position: Q2 2026 in Review

UMB Bank sold out of Beam Therapeutics (BEAM) in Q2 2026, closing a stake of 50 shares — an estimated $1.19K sold.

UMB Bank first reported a position in BEAM in Q4 2021 and held it in 6 quarters. The position peaked at $4K in Q4 2021. 278 funds tracked by Wall St. Rank hold BEAM as of Q2 2026.

  • UMB Bank reported no remaining Beam Therapeutics position as of Q2 2026 after selling out during the quarter.
  • UMB Bank sold 50 Beam Therapeutics shares in Q2 2026, an estimated $1.19K.
  • UMB Bank first reported a position in Beam Therapeutics in Q4 2021 and held it in 6 quarters.
  • UMB Bank's Beam Therapeutics position peaked at $4K in Q4 2021.
  • 278 funds tracked by Wall St. Rank held Beam Therapeutics as of Q2 2026.

Based on UMB Bank's 13F filing for Q2 2026, filed 13 Aug 2026.